Kodiak Sciences Inc Stock 12‑Month Price Target Raised to $129.5, Implies 20% Upside

What happened

Six analysts raised Kodiak Sciences Inc.'s average 12-month stock price target from $121.67 to $129.5, with individual forecasts ranging from $103 to $150 per share. Based on the Nov. 12 closing price, the new average target implies approximately 20% potential upside. The consensus rating remains Buy.

Confirmed

Global impact / market context

Higher analyst targets can shape investor expectations, potentially supporting demand for Kodiak shares if investors see the forecasts as credible. But a price target is an estimate, not a company commitment or guaranteed return, and it does not establish that future results will match analysts’ assumptions.

Analyst inference

The average target rose while the overall rating stayed at Buy, so the update changes analysts’ price expectations without changing their stated consensus view. Forecasts still differ substantially, from $103 to $150, showing that the six analysts do not share one precise valuation.

Confirmed

What to watch

1. Watch for future changes in analyst targets and ratings; further upgrades or downgrades would show whether the current Buy consensus and higher average target are being maintained. Analyst inference
2. Compare any later target with its stated share-price reference date, because the reported 20% potential upside is based specifically on the Nov. 12 closing price. Confirmed
3. Track whether the six analysts revise their forecasts or ratings, since a changing range or Buy, Hold, and Sell balance could alter investor expectations for Kodiak shares. Analyst inference

Evidence

• Original source link unavailable